3B Blackbio

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE994E01018
  • NSEID: 3BBLACKBIO
  • BSEID: 532067
INR
1,205.00
-39 (-3.14%)
BSENSE

Aug 11

BSE+NSE Vol: 7.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 418147,
    "name": "3B Blackbio",
    "stock_name": "3B Blackbio",
    "full_name": "3B Blackbio DX Ltd",
    "name_url": "stocks-analysis/3b-blackbio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,205.00",
    "chg": -39,
    "chgp": "-3.14%",
    "dir": -1,
    "prev_price": "1,244.00",
    "mcapval": "1,034.21 Cr",
    "mcap": "Small Cap",
    "scripcode": 532067,
    "symbol": "3BBLACKBIO",
    "ind_name": "Healthcare Services",
    "ind_code": 18,
    "indexname": "India SENSEX",
    "isin": "INE994E01018",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "7.15 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/3b-blackbio-418147-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "418147",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/3b-blackbio-dx-418147"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2026.",
      "datetime": "05-Aug-2026",
      "details": "3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Intimation To The Holders Of Physical Securities To Furnish KYC Details",
      "datetime": "09-Jul-2026",
      "details": "Intimation to the holders of physical securities to furnish KYC details",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Jul-2026",
      "details": "Special Window for Re-lodgement of Transfer Requests of physical shares",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "3B Blackbio DX Ltd has declared <strong>40%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2026.

05-Aug-2026 | Source : BSE

3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended 30th June 2026.

Intimation To The Holders Of Physical Securities To Furnish KYC Details

09-Jul-2026 | Source : BSE

Intimation to the holders of physical securities to furnish KYC details

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Jul-2026 | Source : BSE

Special Window for Re-lodgement of Transfer Requests of physical shares

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

13 Aug 2026

stock-summary
DIVIDEND

3B Blackbio DX Ltd has declared 40% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available